Who is sponsoring NCT07352319?

NCT07352319 is sponsored by Cairo University.

What drugs are being tested in NCT07352319?

Interventions in NCT07352319: plyometric program.

What condition does NCT07352319 study?

NCT07352319 studies Exercise-Induced Muscle Damage, Rhabdomyolysis, Athletes.

Is NCT07352319 still recruiting?

NCT07352319 is currently completed. Last updated 20 January 2026.

Last reviewed 2026-01-20 · How we verify

NCT07352319

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DOES LOWER BODY PLYOMETRICS CAUSE RHABDOMYOLYSIS IN FEMALE VOLLEYBALL PLAYERS-AN EXPERIMENTAL STUDY

Completed NA Last updated 20 January 2026

What this trial tests

NA trial testing plyometric program in Exercise-Induced Muscle Damage in 60 participants. Completed in 25 October 2022.

Timeline

12 January 2022

Primary endpoint
15 May 2022

25 October 2022

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	60
Start date	12 January 2022
Primary completion	15 May 2022
Estimated completion	25 October 2022
Sites	1 location across Saudi Arabia

Drugs / interventions tested

plyometric program

Conditions studied

Exercise-Induced Muscle Damage — all drugs for Exercise-Induced Muscle Damage →
Rhabdomyolysis — all drugs for Rhabdomyolysis →
Athletes — all drugs for Athletes →

Sponsor

Cairo University

Who can join

Adults 18 to 25, female only, with Exercise-Induced Muscle Damage or Rhabdomyolysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Eight-week interventional study to evaluate whether lower-body plyometric training alters serum creatine phosphokinase (CPK) and creatinine levels in female collegiate volleyball players. Sixty participants were randomized to experimental (plyometrics twice weekly) or control (routine volleyball) groups. Blood sampling occurred at baseline; days 2, 4, and 6; and weeks 1, 2, 4, 6, and 8.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07352319 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 20 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07352319.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing